ArticleJournal of investigative medicine high impact case reports
New Sarcoidosis Diagnosis Following Unresponsive Event During Hemodialysis.
Article in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcoidosis is a systemic disease where extrapulmonary presentation of the disease often goes unrecognized as it overlaps with many disease manifestations. End-stage renal disease (ESRD) can be complicated by hypercalcemia and encephalopathy, both potential signs of sarcoidosis. These numerous extrapulmonary presentations may delay timely diagnosis and treatment. In this case report, a 53-year-old male with ESRD was admitted following an unresponsive episode during routine hemodialysis, later found to have sarcoidosis. Initial presentation notable for hypothermia, tachycardia, leukocytosis, and metabolic derangements. Bronchoalveolar lavage cultures subsequently grew methicillin-sensitive staphylococcus aureus, successfully treated with cefazolin. However, the patient remained encephalopathic and hypercalcemic. Further workup showed nonparathyroid hormone-mediated hypercalcemia with a normal 25-OH vitamin D and elevated 1,25-OH vitamin D, concerning for sarcoidosis, malignancy, or tuberculosis. Additional computed tomography imaging and endobronchial ultrasound-guided biopsy illustrated enlarged lymph nodes with splenomegaly and nonnecrotizing granulomas, respectively, confirming the diagnosis of sarcoidosis. He was started on methylprednisolone, pantoprazole, and trimethoprim/sulfamethoxazole for pneumocystis jirovecii pneumonia prophylaxis; serum calcium levels started to drop, and his mentation improved. While his encephalopathy was initially presumed secondary to his ESRD and infection, further workup revealed sarcoidosis. Untreated sarcoidosis has significant health complications including lung fibrosis, pulmonary hypertension, heart arrhythmias, and neurological deficits. This case highlights the importance of maintaining a broad differential in the setting of critically ill patients as clinical presentations can be multifactorial. Furthermore, patients with a complex medical history such as ESRD on hemodialysis can make concluding sarcoidosis as a diagnosis more difficult.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.